Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Maravai Lifesciences Holdings (MRVI) Total Liabilities: 2020-2025

Historic Total Liabilities for Maravai Lifesciences Holdings (MRVI) over the last 5 years, with Sep 2025 value amounting to $417.3 million.

  • Maravai Lifesciences Holdings' Total Liabilities fell 37.30% to $417.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $417.3 million, marking a year-over-year decrease of 37.30%. This contributed to the annual value of $431.0 million for FY2024, which is 38.21% down from last year.
  • Per Maravai Lifesciences Holdings' latest filing, its Total Liabilities stood at $417.3 million for Q3 2025, which was down 2.72% from $429.0 million recorded in Q2 2025.
  • In the past 5 years, Maravai Lifesciences Holdings' Total Liabilities ranged from a high of $1.4 billion in Q3 2021 and a low of $417.3 million during Q3 2025.
  • In the last 3 years, Maravai Lifesciences Holdings' Total Liabilities had a median value of $667.3 million in 2024 and averaged $778.7 million.
  • As far as peak fluctuations go, Maravai Lifesciences Holdings' Total Liabilities climbed by 23.03% in 2021, and later plummeted by 52.84% in 2024.
  • Maravai Lifesciences Holdings' Total Liabilities (Quarterly) stood at $1.4 billion in 2021, then rose by 0.30% to $1.4 billion in 2022, then crashed by 49.34% to $697.6 million in 2023, then crashed by 38.21% to $431.0 million in 2024, then tumbled by 37.30% to $417.3 million in 2025.
  • Its Total Liabilities was $417.3 million in Q3 2025, compared to $429.0 million in Q2 2025 and $429.5 million in Q1 2025.